DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology.

Joined September 2015
553 Photos and videos
19 Mar 2024
Don’t miss Terry Arnold, PA-C, MBA, and Vice President of DermTech’s Medical Affairs team speak about living with intent and opportunities for Physician Assistants in industry. Listen here: podcasts.apple.com/gb/podcas…
9
2
735
18 Mar 2024
DermTech is proud to support the Association of Military Dermatologists. If you missed us at the 2024 meeting, message us to learn more about TRICARE and VA coverage for the DermTech Melanoma Test.
1
3
780
26 Feb 2024
New clinical study data presented at Winter Clinical: The Trust 2 Study included follow-up evaluations on 2-GEP performance from 5,096 lesions with biopsy results or confirmed clinical follow up. dermtech.com/wp-content/uplo…
1
4
15
1,333
6 Feb 2024
New in JDPA, "Genomics in Dermatology/Precision Medicine- More Than Sequence" by Love et al. highlights the role of genomics in dermatology, including the clinical utility of the DermTech Melanoma Test in guiding biopsy decisions. #Genomics jdpa.scholasticahq.com/artic…

1
374
24 Jan 2024
New article from @DermTimesNow : Maral Kibarian Skelsey, MD, discusses the real-world implications of the new study's findings for dermatology clinicians. Full interview here: dermatologytimes.com/view/ma…
1
6
367
22 Jan 2024
Check out our latest poster, “Non-invasive gene expression analysis rules out melanoma with high negative predictive value regardless of skin phototype” presented at the Winter Clinical Dermatology Conference (January 12-17, 2024). dermtech.com/wp-content/uplo…
4
312
18 Jan 2024
“This is significant progress toward making this test available for patients with Fitzpatrick skin types IV-VI, which is important because ruling out melanoma in individuals with these skin types can be particularly challenging.” businesswire.com/news/home/2…
4
259
16 Jan 2024
"With an NPV that remains at 99% or higher, the DMT provides genomic information for a suspicious pigmented lesion that a clinician may be hesitant to biopsy for various reasons." businesswire.com/news/home/2…
5
207
DermTech retweeted
A recent Winter Clinical Hawaii poster analyzed the ability of @DermTech's 2-GEP assay to detect the expression of LINC00518 and PRAME as a non-invasive assessment of clinically atypical, pigmented skin lesions to rule out #melanoma. dermatologytimes.com/view/de…
1
3
577
12 Jan 2024
“The Trust 2 Study illustrates that a high NPV test such as the DMT can allow physicians to confidently rule out melanoma for their patients,” commented Maral K. Skelsey, M.D., one of the lead Trust 2 Study investigators." bit.ly/41YsYEV
2
234
12 Jan 2024
Headed to Winter Clinical 2024 in Hawaii? Send us a message to meet with our Medical Affairs team and learn more about the real-world utility of the DermTech Melanoma Test and our new Trust 2 Study data. We look forward to seeing you there! #WCH24
1
2
345
8 Jan 2024
“The Trust 2 Study results reaffirm the DMT’s real-world clinical utility to rule out melanoma with a negative predictive value (NPV) that is higher than other currently available methods,” said Loren Clarke, M.D., chief medical officer, DermTech.  investors.dermtech.com/news-…
4
328
15 Dec 2023
Sending warm wishes for a festive holiday season to you and your loved ones! May this time be filled with joy, laughter, and cherished moments. #HappyHolidays
1
227
20 Sep 2023
We are thrilled to announce that Mark Aguillard has joined our team as Chief Commercial Officer! Mark brings over 20 years of leadership experience driving growth through the development and commercialization of multiple, novel molecular diagnostics.
2
1
352
DermTech retweeted
The MRF is proud to announce the 2023 San Diego Miles for Melanoma 5K Presented by @DermTech is now OPEN! Join us Sunday, October 15th at De Anza Cove Park. Click the link below to take advantage of our limited time early bird registration rates. buff.ly/3rxvq7e
2
5
813
12 Jul 2023
We’re pleased to announce a favorable coverage policy for the Pigmented Lesion Assay (PLA), the foundational assay of the DMT, from Highmark Inc. Highmark and its Blue-branded affiliates provide health insurance to approx. 7M members in PA, WV, DE and NY. bit.ly/3Dd911E

1
6
457
28 Jun 2023
The innovative DermTech Gene Lab is: ☑️ CLIA certified ☑️ CAP accredited ☑️ Licensed by the New York State Department of Health Learn more about integrating the DermTech Melanoma Test into your practice: bit.ly/DermTech_HCP. #DermTech #Melanoma #PrecisionGenomics
1
2
7
642
20 Jun 2023
Together, we can help end melanoma deaths by educating patients on the importance of skin exams and integrating the DermTech Melanoma Test into your practice. 🤝 Learn more by clicking the link below. bit.ly/DermTech_HCP #DermTech #melanoma #dermatology #skinchecks
6
407
15 Jun 2023
The DermTech Melanoma Test detects key genomic markers associated with #melanoma to identify higher-risk lesions, potentially at their earliest stages.* *Gerami P, et al. J Am Acad Dermatol. 2017;76(1):114-120. Jackson S, et al. SKIN J Cutan Med. 2020;4(2):105-110.
1
7
425